Chronic Disease
Our work in Chronic Disease
-
Changes in Health Services Use Among Commercially Insured US Populations During the COVID-19 Pandemic
The researchers examine changes in health care use during the first 2 months of the COVID-19 pandemic in March and April of 2020 relative to March and April of 2019 and 2018, and to examine whether changes in use differ by patient’s zip code–level race/ethnicity or income.
Categorized in -
For the Sake of Kidney Patients, Vote No on Proposition 23
As a kidney doctor and health policy researcher, I am appalled that patients have become a bargaining chip in a game that could result in massive dialysis shortages, increased costs, and death.
Categorized in -
Improved Survival for Individuals with Common Chronic Conditions in the Medicare Population
It is well established that the United States lags behind peer nations in life expectancy, but it is less established that there is heterogeneity in life expectancy trends. We compared mortality trends from 2004 to 2014 for the United States with 17 high-income countries for persons under and over 65. The United States ranked last […]
Categorized in -
Incidence, Prevalence, and Risk Factors of Infectious Uveitis and Scleritis in the United States: A Claims-Based Analysis
Ocular inflammation causes significant visual morbidity in the United States, yet little is known about the epidemiology of infectious uveitis and scleritis. This study aims to evaluate the epidemiology of infectious uveitis/scleritis employing a large national medical claims database.
Categorized in -
The “Advancing American Kidney Health” Executive Order: Challenges and Opportunities for the Large Dialysis Organizations
This perspective in the American Journal of Kidney Diseases examines how the “Advancing American Kidney Health” Executive Order (AAKH) might reshape the US dialysis market.
Categorized in -
Lifetime Burden of Adult Congenital Heart Disease in the USA Using a Microsimulation Model
There is a significant burden of disease among individuals with CHD; the disease affects quality of life, disability, life expectancy, medical spending, chronic disease, as well as employment and education outcomes.
Categorized in -
California Leads in Public Investment in Biomedical Innovation and It Is Beginning to Show Returns
Schaeffer Center research indicates public investment into biomedical innovation yields substantial economic and social return in California.
Categorized in -
Schaeffer Study Shows Public Investment in Stem Cell Research Makes Economic Sense
Stem cell research holds promise for generating breakthroughs against conditions including Alzheimer’s, cancer, diabetes, heart disease, vision loss—and even COVID-19.
Categorized in -
The Economic Case for Public Investment in Stem Cell Research
Our analysis shows the measure resulted in over 56,000 jobs created and added approximately $10 billion to the state’s economy.
Categorized in -
Early Delays in Insurance Coverage and Long- Term Use of Home- Based Peritoneal Dialysis
The study analyzes Medicare coverage delays among the uninsured and their effect on long-term peritoneal dialysis use.
Categorized in